---
title: "Your drug modality"
id: "192"
type: "page"
slug: "drug-modalities"
published_at: "2025-07-09T14:22:49+00:00"
modified_at: "2026-03-20T09:11:29+00:00"
url: "https://innocorepharma.com/drug-modalities/"
markdown_url: "https://innocorepharma.com/drug-modalities.md"
---

Drug modalities

# Developing stable and scalable Long-Acting Injectable (LAI) dosage forms for peptides and biologics

Innocore’s SynBiosys® polymeric technology platform enables customizable, long-acting drug release up to 12 months; ideal for complex peptide and biologic APIs requiring precise control, scalability, and reliable therapeutic performance.

The technology is proven and well differentiated from other platforms, and supports a wide range of advanced injectable, biodegradable dosage forms, including microspheres, implants and in-situ forming depots.

[Peptide Formulation & Delivery Systems – Innocore Advanced controlled peptide delivery Discover more](https://innocorepharma.com/drug-modalities/peptides/)
[Biologics Formulation – Innocore Unique long-acting dosage forms for biologicals Discover more](https://innocorepharma.com/drug-modalities/biologics/)
[Oligonucleotides Engineering the next generation of long-acting, high impact oligonucleotide therapeutics Discover more](https://innocorepharma.com/drug-modalities/oligonucleotides/)
[Small molecules Extended released and enhanced efficiency for clinically validated APIs Discover more](https://innocorepharma.com/drug-modalities/small-molecules/)
[New modalities Addressing the challenges of short half-life and formulation sensitivity Discover more](https://innocorepharma.com/drug-modalities/new-modalities/)

More About Innocore

[About Explore Innocore](https://innocorepharma.com/company/)

[Technologies Discover our technologies](https://innocorepharma.com/technologies/)

[Partnering Partner with us](https://innocorepharma.com/company/partnering-with-innocore/)